Gyre Therapeutics
GYRE
GYRE
46 hedge funds and large institutions have $51.4M invested in Gyre Therapeutics in 2019 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 12 increasing their positions, 18 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
10% more funds holding
Funds holding: 42 → 46 (+4)
0.11% more ownership
Funds ownership: 8.26% → 8.36% (+0.11%)
33% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 18
Holders
46
Holding in Top 10
3
Calls
$117K
Puts
$78K
Top Buyers
| 1 | +$2.09M | |
| 2 | +$855K | |
| 3 | +$850K | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$688K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$540K |
Top Sellers
| 1 | -$2.27M | |
| 2 | -$1.13M | |
| 3 | -$994K | |
| 4 |
FM
Fondren Management
Houston,
Texas
|
-$336K |
| 5 |
Morgan Stanley
New York
|
-$277K |